Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

TSN222 in Subjects With Advanced Solid Tumors or Lymphomas

NCT05842785

Conditions: Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Fudan Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

NCT04014374

Conditions: ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more
Locations: CIBMTR Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

NCT06503094

Conditions: B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

NCT06430736

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Insel Gruppe AG Bern, Canton of Bern, Switzerland

View Trial Details

Recruiting

Establishing Prospective Mediastinal Tumor Database of PUMCH

NCT06421805

Conditions: Cysts, Endocrine System Diseases, Germ Cell Tumor, +28 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension

NCT05678621

Conditions: Agammaglobulinemia, Blood Protein Disorders, Haematological Malignancy, +16 more
Locations: Canberra Hospital Garran, Australian Capital Territory, Australia

Concord Hospital Concord, New South Wales, Australia

Royal North Shore St Leonards, New South Wales, Australia

Monash Medical Centre Clayton, Victoria, Australia

View Trial Details

Recruiting

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

NCT05477264

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea

View Trial Details

Recruiting

Italian Observational Study on CAR-T Therapy for Lymphoma

NCT06339255

Conditions: Diffuse Low Grade B-Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations: Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy

View Trial Details

Recruiting

Effects of Exercise Training in Survivors of Lymphoma

NCT06270667

Conditions: Behavior, Cardiotoxicity, Cardiovascular Diseases, +18 more
Locations: Norweigan School of Sport Sciences Oslo, Norway

Helena Igelström Uppsala, Sweden

View Trial Details

Recruiting

The Pathogenesis and Prognostic Factors of Lymphoma

NCT06203652

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: Zhongshan Hospital，Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions